Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Cardiac Biomarkers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Cardiac Biomarkers (online CE course) »
How to Subscribe
Individual course$20 Add to cart

References

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays. Fred S. Apple Paul O. Collinson and for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Clinical Chemistry January 2012 vol. 58 no. 1 54-61.
Arneson W, Brickell J, eds.Clinical Chemistry: A Laboratory Perspective. Philadelphia: FA Davis; 2007.
Burtis CA, Bruns DE, eds. Tietz Fundamentals of Clinical Chemistry. 7th ed. St. Louis, MO: Elsevier Saunders; 2015.
Carreiro-Lewandowski E. Update on cardiac markers. Lab Med. 2006;37:597-605.
D'Amore PJ. Evolution of C-reactive protein as a cardiac risk factor. Lab Med. 2005;36:234-238.
Dotsenko O, Chackathayil J, Lip GY. Cardiac biomarkers:myths, facts and future horizons. Expert Review of Molecular Diagnostics. 2007;7:693-697.
Foley, K. BNP: a novel biomarker. Advance for Medical Laboratory Professionals. August 25, 2008:9.
Kaplan LA, Pesce AJ, eds. Clinical Chemistry Theory, Analysis, Correlation. 5th ed. St. Louis, MO: Mosby Elsevier Science; 2010.
McDowell J. Reviewing the evidence for BNP, NT-proBNP testing. Clin Lab News. 2006;32:1, 3, 5.
Rollins G. cTn and MI - what's the diagnosis? Clin Lab News. 2009;35:1, 3-4.
Rollins, G. The BNP debate. Clin Lab News. 2009;35:1,3-4.
Schreiber D, Miller SM. Cardiac markers. eMedicine. Updated January, 8 2017. Available at: http://emedicine.medscape.com/article/811905-print. Accessed June 11, 2018.
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation 2007;116:2634-2653.